Liu, N.; Zhang, H.; Zhang, C.; Li, Z.; Huang, L.; Sun, J.; Qi, J.; Deng, X.; Huang, N.; Mu, Y.;
et al. DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. Cancers 2023, 15, 5228.
https://doi.org/10.3390/cancers15215228
AMA Style
Liu N, Zhang H, Zhang C, Li Z, Huang L, Sun J, Qi J, Deng X, Huang N, Mu Y,
et al. DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. Cancers. 2023; 15(21):5228.
https://doi.org/10.3390/cancers15215228
Chicago/Turabian Style
Liu, Nanbin, Hailong Zhang, Chunli Zhang, Zeyu Li, Limin Huang, Jin Sun, Junan Qi, Xi Deng, Na Huang, Yanhua Mu,
and et al. 2023. "DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC" Cancers 15, no. 21: 5228.
https://doi.org/10.3390/cancers15215228
APA Style
Liu, N., Zhang, H., Zhang, C., Li, Z., Huang, L., Sun, J., Qi, J., Deng, X., Huang, N., Mu, Y., Li, Z., & Tian, H.
(2023). DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. Cancers, 15(21), 5228.
https://doi.org/10.3390/cancers15215228